Interventional nanotheranostics in hepatocellular carcinoma
Interventional nanotheranostics is a system of drug delivery that does a dual function; along with the therapeutic action, it also does have diagnostic features. This method helps in early detection, targeted delivery, and the least chances of damage to surrounding tissue. It ensures the highest eff...
Gespeichert in:
| Veröffentlicht in: | Nanotheranostics (Sydney, NSW) NSW), 2023, Vol.7 (2), p.128-141 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 141 |
|---|---|
| container_issue | 2 |
| container_start_page | 128 |
| container_title | Nanotheranostics (Sydney, NSW) |
| container_volume | 7 |
| creator | Chavda, Vivek P Balar, Pankti C Patel, Srushti B |
| description | Interventional nanotheranostics is a system of drug delivery that does a dual function; along with the therapeutic action, it also does have diagnostic features. This method helps in early detection, targeted delivery, and the least chances of damage to surrounding tissue. It ensures the highest efficiency for the management of the disease. Imaging is the near future for the quickest and most accurate detection of disease. After combing both effective measures, it ensures the most meticulous drug delivery system. Nanoparticles such as Gold NPs, Carbon NPs, Silicon NPS, etc. The article emphasizes on effect of this delivery system in the treatment of Hepatocellular Carcinoma. It is one of the widely spreading diseases and theranostics is trying to make the scenario better. The review suggests the pitfall of the current system and how theranostics can help. It describes the mechanism used to generate its effect and believes that interventional nanotheranostics do have a future with rainbow color. The article also describes the current hindrance to the flourishing of this miraculous technology. |
| doi_str_mv | 10.7150/ntno.80120 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9925354</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2777405624</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2230-13df7acc7823ee7bef03df5cb9ae7ae17c6875bac5dcd7ce86a6d12490ee14513</originalsourceid><addsrcrecordid>eNpVUF1Lw0AQPESxpfbFHyB5FCH1PnK5BEGQ4keh4Is-H5vLxkbSu3qXFPz3JraW-jTL7jA7M4RcMjpTTNJb21o3yyjj9ISMOadprBKWnR7NIzIN4ZNSynLGhcjPyUikKhdCJmNyt7At-i3atnYWmsiCde0KfQ-hrU2IahutcAOtM9g0XQM-MuBNbd0aLshZBU3A6R4n5P3p8W3-Ei9fnxfzh2VsOBc0ZqKsFBijMi4QVYEV7TfSFDmgAmTKpJmSBRhZmlIZzFJIS8aTnCKyRDIxIfc73U1XrLE0vVkPjd74eg3-Wzuo9f-LrVf6w211nnPZp-wFrvcC3n11GFq9rsOQByy6LmiulEqoTPlAvdlRjXcheKwObxjVQ-F6KFz_Ft6Tr46NHah_9YofouR-1A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2777405624</pqid></control><display><type>article</type><title>Interventional nanotheranostics in hepatocellular carcinoma</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Chavda, Vivek P ; Balar, Pankti C ; Patel, Srushti B</creator><creatorcontrib>Chavda, Vivek P ; Balar, Pankti C ; Patel, Srushti B</creatorcontrib><description>Interventional nanotheranostics is a system of drug delivery that does a dual function; along with the therapeutic action, it also does have diagnostic features. This method helps in early detection, targeted delivery, and the least chances of damage to surrounding tissue. It ensures the highest efficiency for the management of the disease. Imaging is the near future for the quickest and most accurate detection of disease. After combing both effective measures, it ensures the most meticulous drug delivery system. Nanoparticles such as Gold NPs, Carbon NPs, Silicon NPS, etc. The article emphasizes on effect of this delivery system in the treatment of Hepatocellular Carcinoma. It is one of the widely spreading diseases and theranostics is trying to make the scenario better. The review suggests the pitfall of the current system and how theranostics can help. It describes the mechanism used to generate its effect and believes that interventional nanotheranostics do have a future with rainbow color. The article also describes the current hindrance to the flourishing of this miraculous technology.</description><identifier>ISSN: 2206-7418</identifier><identifier>EISSN: 2206-7418</identifier><identifier>DOI: 10.7150/ntno.80120</identifier><identifier>PMID: 36793354</identifier><language>eng</language><publisher>Australia: Ivyspring International Publisher</publisher><subject>Carcinoma, Hepatocellular - pathology ; Drug Carriers - therapeutic use ; Drug Delivery Systems ; Humans ; Liver Neoplasms - pathology ; Review ; Theranostic Nanomedicine - methods</subject><ispartof>Nanotheranostics (Sydney, NSW), 2023, Vol.7 (2), p.128-141</ispartof><rights>The author(s).</rights><rights>The author(s) 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2230-13df7acc7823ee7bef03df5cb9ae7ae17c6875bac5dcd7ce86a6d12490ee14513</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925354/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925354/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,4024,27923,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36793354$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chavda, Vivek P</creatorcontrib><creatorcontrib>Balar, Pankti C</creatorcontrib><creatorcontrib>Patel, Srushti B</creatorcontrib><title>Interventional nanotheranostics in hepatocellular carcinoma</title><title>Nanotheranostics (Sydney, NSW)</title><addtitle>Nanotheranostics</addtitle><description>Interventional nanotheranostics is a system of drug delivery that does a dual function; along with the therapeutic action, it also does have diagnostic features. This method helps in early detection, targeted delivery, and the least chances of damage to surrounding tissue. It ensures the highest efficiency for the management of the disease. Imaging is the near future for the quickest and most accurate detection of disease. After combing both effective measures, it ensures the most meticulous drug delivery system. Nanoparticles such as Gold NPs, Carbon NPs, Silicon NPS, etc. The article emphasizes on effect of this delivery system in the treatment of Hepatocellular Carcinoma. It is one of the widely spreading diseases and theranostics is trying to make the scenario better. The review suggests the pitfall of the current system and how theranostics can help. It describes the mechanism used to generate its effect and believes that interventional nanotheranostics do have a future with rainbow color. The article also describes the current hindrance to the flourishing of this miraculous technology.</description><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Drug Carriers - therapeutic use</subject><subject>Drug Delivery Systems</subject><subject>Humans</subject><subject>Liver Neoplasms - pathology</subject><subject>Review</subject><subject>Theranostic Nanomedicine - methods</subject><issn>2206-7418</issn><issn>2206-7418</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUF1Lw0AQPESxpfbFHyB5FCH1PnK5BEGQ4keh4Is-H5vLxkbSu3qXFPz3JraW-jTL7jA7M4RcMjpTTNJb21o3yyjj9ISMOadprBKWnR7NIzIN4ZNSynLGhcjPyUikKhdCJmNyt7At-i3atnYWmsiCde0KfQ-hrU2IahutcAOtM9g0XQM-MuBNbd0aLshZBU3A6R4n5P3p8W3-Ei9fnxfzh2VsOBc0ZqKsFBijMi4QVYEV7TfSFDmgAmTKpJmSBRhZmlIZzFJIS8aTnCKyRDIxIfc73U1XrLE0vVkPjd74eg3-Wzuo9f-LrVf6w211nnPZp-wFrvcC3n11GFq9rsOQByy6LmiulEqoTPlAvdlRjXcheKwObxjVQ-F6KFz_Ft6Tr46NHah_9YofouR-1A</recordid><startdate>2023</startdate><enddate>2023</enddate><creator>Chavda, Vivek P</creator><creator>Balar, Pankti C</creator><creator>Patel, Srushti B</creator><general>Ivyspring International Publisher</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>2023</creationdate><title>Interventional nanotheranostics in hepatocellular carcinoma</title><author>Chavda, Vivek P ; Balar, Pankti C ; Patel, Srushti B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2230-13df7acc7823ee7bef03df5cb9ae7ae17c6875bac5dcd7ce86a6d12490ee14513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Drug Carriers - therapeutic use</topic><topic>Drug Delivery Systems</topic><topic>Humans</topic><topic>Liver Neoplasms - pathology</topic><topic>Review</topic><topic>Theranostic Nanomedicine - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chavda, Vivek P</creatorcontrib><creatorcontrib>Balar, Pankti C</creatorcontrib><creatorcontrib>Patel, Srushti B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nanotheranostics (Sydney, NSW)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chavda, Vivek P</au><au>Balar, Pankti C</au><au>Patel, Srushti B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interventional nanotheranostics in hepatocellular carcinoma</atitle><jtitle>Nanotheranostics (Sydney, NSW)</jtitle><addtitle>Nanotheranostics</addtitle><date>2023</date><risdate>2023</risdate><volume>7</volume><issue>2</issue><spage>128</spage><epage>141</epage><pages>128-141</pages><issn>2206-7418</issn><eissn>2206-7418</eissn><abstract>Interventional nanotheranostics is a system of drug delivery that does a dual function; along with the therapeutic action, it also does have diagnostic features. This method helps in early detection, targeted delivery, and the least chances of damage to surrounding tissue. It ensures the highest efficiency for the management of the disease. Imaging is the near future for the quickest and most accurate detection of disease. After combing both effective measures, it ensures the most meticulous drug delivery system. Nanoparticles such as Gold NPs, Carbon NPs, Silicon NPS, etc. The article emphasizes on effect of this delivery system in the treatment of Hepatocellular Carcinoma. It is one of the widely spreading diseases and theranostics is trying to make the scenario better. The review suggests the pitfall of the current system and how theranostics can help. It describes the mechanism used to generate its effect and believes that interventional nanotheranostics do have a future with rainbow color. The article also describes the current hindrance to the flourishing of this miraculous technology.</abstract><cop>Australia</cop><pub>Ivyspring International Publisher</pub><pmid>36793354</pmid><doi>10.7150/ntno.80120</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2206-7418 |
| ispartof | Nanotheranostics (Sydney, NSW), 2023, Vol.7 (2), p.128-141 |
| issn | 2206-7418 2206-7418 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9925354 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; PubMed Central |
| subjects | Carcinoma, Hepatocellular - pathology Drug Carriers - therapeutic use Drug Delivery Systems Humans Liver Neoplasms - pathology Review Theranostic Nanomedicine - methods |
| title | Interventional nanotheranostics in hepatocellular carcinoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T10%3A10%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interventional%20nanotheranostics%20in%20hepatocellular%20carcinoma&rft.jtitle=Nanotheranostics%20(Sydney,%20NSW)&rft.au=Chavda,%20Vivek%20P&rft.date=2023&rft.volume=7&rft.issue=2&rft.spage=128&rft.epage=141&rft.pages=128-141&rft.issn=2206-7418&rft.eissn=2206-7418&rft_id=info:doi/10.7150/ntno.80120&rft_dat=%3Cproquest_pubme%3E2777405624%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2777405624&rft_id=info:pmid/36793354&rfr_iscdi=true |